Arch Therapeutics (ARTH, $0.24) was one of top quarterly gainers, jumping to $0.24 per share. A.I.dvisor analyzed 849 stocks in the Biotechnology Industry over the last three months, and discovered that of them (3) charted an Uptrend while of them (6) trended down.